Erin Campany

Human Resources Officer at MIRUM PHARMACEUTICALS, INC.

59 year

Health Technology

Consumer Services

Profile

Erin Campany is currently Chief People Officer at Mirum Pharmaceuticals, Inc. since 2025.
Former positions include Senior Director-Global Human Resources at Acorda Therapeutics, Inc. from 2013 to 2017, Head-Human Resources at Immune Design Corp.
from 2017 to 2019, and Vice President-Human Resources at Rapt Therapeutics, Inc. Education includes undergraduate studies at San Jose State University.

Erin Campany active positions

Companies	Position	Start
MIRUM PHARMACEUTICALS, INC.	Human Resources Officer	2021-12-31

All active positions of Erin Campany

Former positions of Erin Campany

Companies	Position	End
IMMUNE DESIGN CORP	Human Resources Officer	2019-06-30
ACORDA THERAPEUTICS, INC.	Human Resources Officer	2017-08-31
RAPT THERAPEUTICS, INC.	Human Resources Officer	-

See the detail of Erin Campany's experience

Training of Erin Campany

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Erin Campany's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Acorda Therapeutics, Inc. Acorda Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops neurology therapies	Health Technology
San Jose State University San Jose State University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Immune Design Corp. Immune Design Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical and clinical-stage immunotherapy company	Health Technology
Rapt Therapeutics, Inc. Rapt Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes oral small molecule therapies for patients	Health Technology
Mirum Pharmaceuticals, Inc. Mirum Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage therapeutics company developing a novel approach for treating cholestasis liver diseases	Health Technology